Veracyte ROA 2012-2025 | VCYT
Current and historical return on assets (ROA) values for Veracyte (VCYT) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
| Veracyte ROA - Return on Assets Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Total Assets | Return on Assets |
| 2025-09-30 | $0.03B | $1.37B | 2.25% |
| 2025-06-30 | $0.03B | $1.34B | 1.99% |
| 2025-03-31 | $0.03B | $1.32B | 2.58% |
| 2024-12-31 | $0.02B | $1.30B | 1.92% |
| 2024-09-30 | $-0.01B | $1.28B | -0.75% |
| 2024-06-30 | $-0.05B | $1.23B | -4.62% |
| 2024-03-31 | $-0.07B | $1.20B | -5.91% |
| 2023-12-31 | $-0.07B | $1.12B | -6.49% |
| 2023-09-30 | $-0.05B | $1.13B | -4.35% |
| 2023-06-30 | $-0.03B | $1.16B | -2.52% |
| 2023-03-31 | $-0.03B | $1.16B | -2.71% |
| 2022-12-31 | $-0.04B | $1.16B | -3.22% |
| 2022-09-30 | $-0.04B | $1.13B | -3.80% |
| 2022-06-30 | $-0.05B | $1.14B | -4.18% |
| 2022-03-31 | $-0.05B | $1.17B | -4.20% |
| 2021-12-31 | $-0.08B | $1.19B | -6.87% |
| 2021-09-30 | $-0.07B | $1.19B | -7.90% |
| 2021-06-30 | $-0.06B | $1.03B | -8.50% |
| 2021-03-31 | $-0.07B | $1.03B | -11.86% |
| 2020-12-31 | $-0.04B | $0.46B | -9.76% |
| 2020-09-30 | $-0.03B | $0.45B | -10.85% |
| 2020-06-30 | $-0.03B | $0.26B | -11.71% |
| 2020-03-31 | $-0.02B | $0.27B | -8.35% |
| 2019-12-31 | $-0.01B | $0.28B | -5.27% |
| 2019-09-30 | $-0.01B | $0.26B | -4.23% |
| 2019-06-30 | $-0.01B | $0.25B | -7.14% |
| 2019-03-31 | $-0.02B | $0.12B | -13.99% |
| 2018-12-31 | $-0.02B | $0.12B | -23.40% |
| 2018-09-30 | $-0.03B | $0.12B | -32.34% |
| 2018-06-30 | $-0.03B | $0.07B | -40.13% |
| 2018-03-31 | $-0.03B | $0.07B | -38.51% |
| 2017-12-31 | $-0.03B | $0.08B | -34.88% |
| 2017-09-30 | $-0.03B | $0.08B | -28.42% |
| 2017-06-30 | $-0.03B | $0.09B | -28.41% |
| 2017-03-31 | $-0.03B | $0.09B | -34.22% |
| 2016-12-31 | $-0.03B | $0.10B | -37.58% |
| 2016-09-30 | $-0.04B | $0.07B | -46.05% |
| 2016-06-30 | $-0.04B | $0.08B | -48.25% |
| 2016-03-31 | $-0.04B | $0.08B | -44.58% |
| 2015-12-31 | $-0.03B | $0.08B | -46.26% |
| 2015-09-30 | $-0.03B | $0.08B | -47.89% |
| 2015-06-30 | $-0.03B | $0.08B | -48.00% |
| 2015-03-31 | $-0.03B | $0.06B | -47.69% |
| 2014-12-31 | $-0.03B | $0.07B | -43.32% |
| 2014-09-30 | $-0.03B | $0.07B | -38.36% |
| 2014-06-30 | $-0.03B | $0.07B | -42.62% |
| 2014-03-31 | $-0.03B | $0.07B | -49.26% |
| 2013-12-31 | $-0.03B | $0.08B | -76.34% |
| 2013-06-30 | $-0.02B | $0.03B | -266.67% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $2.845B | $0.446B |
| Veracyte, Inc. is a diagnostics company. It is focused on discovering, developing and commercializing molecular cytology solutions. The Company provides Afirma Thyroid FNA Analysis, which helps physicians in reducing unnecessary diagnostic surgeries for patients with thyroid nodules. Veracyte is also developing Afirma Malignant GEC test. It serves endocrinologists, radiologists, and head and neck specialists. Veracyte, Inc. is headquartered in South San Francisco, California. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $198.062B | 23.05 |
| Intuitive Surgical (ISRG) | United States | $176.187B | 67.96 |
| IDEXX Laboratories (IDXX) | United States | $51.802B | 49.63 |
| Edwards Lifesciences (EW) | United States | $46.035B | 30.99 |
| Alcon (ALC) | Switzerland | $39.268B | 26.46 |
| IQVIA Holdings (IQV) | United States | $30.174B | 16.30 |
| Mettler-Toledo (MTD) | United States | $28.306B | 32.55 |
| DexCom (DXCM) | United States | $26.580B | 36.64 |
| STERIS (STE) | Ireland | $23.878B | 24.15 |
| Waters (WAT) | United States | $19.603B | 25.07 |
| Coloplast (CLPBY) | Denmark | $17.488B | 26.76 |
| Hologic (HOLX) | United States | $16.763B | 17.54 |
| SONOVA HOLDING (SONVY) | Switzerland | $15.540B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $13.942B | 11.56 |
| Penumbra (PEN) | United States | $13.247B | 93.18 |
| Globus Medical (GMED) | United States | $11.813B | 24.79 |
| SARTORIUS (SSSGY) | Germany | $7.976B | 46.32 |
| Masimo (MASI) | United States | $7.254B | 23.24 |
| Sysmex ADR (SSMXY) | Japan | $6.295B | 20.00 |
| Glaukos (GKOS) | United States | $6.262B | 0.00 |
| Teleflex (TFX) | United States | $4.727B | 7.53 |
| TransMedics (TMDX) | United States | $4.555B | 53.97 |
| LivaNova (LIVN) | United Kingdom | $3.627B | 19.60 |
| Integer Holdings (ITGR) | United States | $3.055B | 14.34 |
| Elekta AB (EKTAY) | Sweden | $2.250B | 21.05 |
| Nihon Kohden (NHNKY) | Japan | $2.036B | 22.47 |
| UFP Technologies (UFPT) | United States | $2.032B | 26.83 |
| Alphatec Holdings (ATEC) | United States | $2.001B | 0.00 |
| Artivion (AORT) | United States | $1.900B | 87.17 |
| Pulse Biosciences (PLSE) | United States | $1.711B | 0.00 |
| PROCEPT BioRobotics (PRCT) | United States | $1.593B | 0.00 |
| AxoGen (AXGN) | United States | $1.564B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.333B | 0.00 |
| IRadimed (IRMD) | United States | $1.311B | 58.90 |
| OPKO Health (OPK) | United States | $0.960B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $0.871B | 4.72 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.702B | 14.00 |
| SiBone (SIBN) | United States | $0.661B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.632B | 0.00 |
| Beta Bionics (BBNX) | United States | $0.622B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.617B | 35.87 |
| Pacific Biosciences Of California (PACB) | United States | $0.556B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.535B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.504B | 13.13 |
| NeuroPace (NPCE) | United States | $0.485B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.469B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.432B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.380B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.335B | 55.88 |
| RxSight (RXST) | United States | $0.330B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.311B | 2.32 |
| Sight Sciences (SGHT) | United States | $0.292B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.286B | 0.00 |
| 908 Devices (MASS) | United States | $0.239B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.236B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.186B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.183B | 0.00 |
| Inogen (INGN) | United States | $0.166B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.165B | 0.00 |
| CVRx (CVRX) | United States | $0.159B | 0.00 |
| LENSAR (LNSR) | United States | $0.148B | 0.00 |
| Nano-X Imaging (NNOX) | Israel | $0.146B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.134B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.129B | 0.00 |
| Zomedica (ZOMDF) | United States | $0.127B | 0.00 |
| Neuronetics (STIM) | United States | $0.123B | 0.00 |
| Hyperfine (HYPR) | United States | $0.107B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.078B | 0.00 |
| Solana (HSDT) | United States | $0.078B | 0.00 |
| QT Imaging Holdings (QTIH) | United States | $0.078B | 0.00 |
| DarioHealth (DRIO) | United States | $0.074B | 0.00 |
| InspireMD (NSPR) | United States | $0.073B | 0.00 |
| QT Imaging Holdings (QTI) | United States | $0.067B | 0.00 |
| Positron (POSC) | United States | $0.065B | 0.00 |
| Accuray (ARAY) | United States | $0.058B | 0.00 |
| Spectral AI (MDAI) | United States | $0.047B | 0.00 |
| Precision Optics (POCI) | United States | $0.039B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.035B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.026B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.022B | 0.00 | |
| Envoy Medical (COCH) | United States | $0.019B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.016B | 0.00 |
| Check-Cap (MBAI) | Israel | $0.013B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.012B | 0.00 |
| NexGel (NXGL) | United States | $0.011B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.011B | 0.00 |
| PAVmed (PAVM) | United States | $0.010B | 0.00 |
| Tenon Medical (TNON) | United States | $0.008B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.006B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.004B | 0.00 |
| Nuwellis (NUWE) | United States | $0.004B | 0.00 |
| ENvue Medical (FEED) | United States | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.003B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |